Evidence map›Paper›PMID 24651521›Full record

ArticlePLoS pathogens2014

DHX36 enhances RIG-I signaling by facilitating PKR-mediated antiviral stress granule formation.

Ji-Seung Yoo, Kiyohiro Takahasi, Chen Seng Ng, Ryota Ouda, Koji Onomoto, Mitsutoshi Yoneyama, Janice Ching Lai, Simon Lattmann, Yoshikuni Nagamine, Tadashi Matsui and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 163 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. A closer look at mammalian antiviral condensates.Biochemical Society transactions · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Understanding the impact ofFrontiers in molecular biosciences · 2024
    Review
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Ji-Seung YooLaboratory of Molecular Genetics, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Kiyohiro TakahasiLaboratory of Molecular Genetics, Institute for Virus Research, Kyoto University, Kyoto, Japan; Institute for Innovative NanoBio Drug Discovery and Development, Graduate School of Pharmaceutical Science, Kyoto University, Kyoto, Japan.
Chen Seng NgLaboratory of Molecular Genetics, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Ryota OudaLaboratory of Molecular Genetics, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Koji OnomotoDivision of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chuo-ku, Chiba, Japan.
Mitsutoshi YoneyamaDivision of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chuo-ku, Chiba, Japan.
Janice Ching LaiFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Simon LattmannFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Yoshikuni NagamineFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Tadashi MatsuiDepartment of Biochemistry I, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Kuniyoshi IwabuchiDepartment of Biochemistry I, School of Medicine, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Hiroki KatoLaboratory of Molecular Genetics, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Takashi FujitaLaboratory of Molecular Genetics, Institute for Virus Research, Kyoto University, Kyoto, Japan; Laboratory of Molecular Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Kyoto University · JPFriedrich Miescher Institute · CHChiba University · JPKanazawa Medical University · JPKyoto Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RIG-I is a DExD/H-box RNA helicase and functions as a critical cytoplasmic sensor for RNA viruses to initiate antiviral interferon (IFN) responses. Here we demonstrate that another DExD/H-box RNA helicase DHX36 is a key molecule for RIG-I signaling by regulating double-stranded RNA (dsRNA)-dependent protein kinase (PKR) activation, which has been shown to be essential for the formation of antiviral stress granule (avSG). We found that DHX36 and PKR form a complex in a dsRNA-dependent manner. By forming this complex, DHX36 facilitates dsRNA binding and phosphorylation of PKR through its ATPase/helicase activity. Using DHX36 KO-inducible MEF cells, we demonstrated that DHX36 deficient cells showed defect in IFN production and higher susceptibility in RNA virus infection, indicating the physiological importance of this complex in host defense. In summary, we identify a novel function of DHX36 as a critical regulator of PKR-dependent avSG to facilitate viral RNA recognition by RIG-I-like receptor (RLR).

Indexed as

Cytoplasmic GranulesDEAD Box Protein 58DEAD-box RNA HelicaseseIF-2 KinaseEnzyme-Linked Immunosorbent AssayFluorescent Antibody TechniqueGene Knockout TechniquesHEK293 CellsHeLa CellsHumansImmunoprecipitationReceptors, ImmunologicReverse Transcriptase Polymerase Chain ReactionRNA, Double-StrandedRNA, Small InterferingRNA, ViralDEAD Box Protein 58DEAD-box RNA HelicasesDHX36 protein, humaneIF-2 KinaseReceptors, ImmunologicRIGI protein, humanRNA, Double-StrandedRNA, Small InterferingRNA, Viral

Identifiers

PMID24651521
PMCPMC3961341
OpenAlexW2006600110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.